Homocysteine, the kidney, and vascular disease.

Homocysteine, the kidney, and vascular disease.

Bibliografische gegevens
Hoofdauteurs:	Haynes, R, Clarke, R
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2012

Gelijkaardige items

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease
door: Haynes, R, et al.
Gepubliceerd in: (2012)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
door: Clarke, R, et al.
Gepubliceerd in: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
door: Clarke, R, et al.
Gepubliceerd in: (2011)

Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
door: Clarke, R, et al.
Gepubliceerd in: (2007)

Homocysteine and cardiovascular disease. Overview.
door: Clarke, R
Gepubliceerd in: (1998)

Homocysteine and coronary heart disease.
door: Clarke, R, et al.
Gepubliceerd in: (2002)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
door: Clarke, R
Gepubliceerd in: (2011)

Homocysteine and prediction of coronary heart disease and stroke
door: Clarke, R, et al.
Gepubliceerd in: (2003)

Homocysteine, renal function, and risk of cardiovascular disease.
door: Clarke, R, et al.
Gepubliceerd in: (2003)

Homocysteine-lowering trials for prevention of heart disease and stroke.
door: Clarke, R
Gepubliceerd in: (2005)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
door: Clarke, R
Gepubliceerd in: (2009)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
door: Clarke, R, et al.
Gepubliceerd in: (2005)

Homocysteine and risk of cardiovascular disease and venous thrombosis
door: Clarke, R, et al.
Gepubliceerd in: (2003)

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.
door: Clarke, R
Gepubliceerd in: (2002)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
door: Clarke, R, et al.
Gepubliceerd in: (1998)

Lipids in chronic kidney disease.
door: Lewis, D, et al.
Gepubliceerd in: (2010)

Homocysteine, B vitamins, and the risk of dementia.
door: Clarke, R
Gepubliceerd in: (2007)

Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
door: Preiss, D, et al.
Gepubliceerd in: (2022)

Generate vascularized kidney organoids for studying kidney development
door: Zhang, Tian
Gepubliceerd in: (2020)

Vascular Homocysteine vs 5-Methyl-Tetrahydrofolate as Regulators of Vascular Redox and Endothelial Function in Human Vessels
door: Antoniades, C, et al.
Gepubliceerd in: (2008)

Vascular Homocysteine Versus 5-Methyl-Tetrahydrofolate As Regulators of Vascular Redox and Endothelial Function in Human Vessels
door: Antoniades, C, et al.
Gepubliceerd in: (2009)

Homocysteine, B vitamins, and cardiovascular disease
door: Refsum, H, et al.
Gepubliceerd in: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
door: Refsum, H, et al.
Gepubliceerd in: (2006)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
door: Holman, R, et al.
Gepubliceerd in: (2001)

Neprilysin inhibition in chronic kidney disease.
door: Judge, P, et al.
Gepubliceerd in: (2014)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
door: Clarke, R, et al.
Gepubliceerd in: (2007)

Commentary: Controversies in NICE guidance on chronic kidney disease.
door: Landray, M, et al.
Gepubliceerd in: (2008)

Commentary: Controversies in NICE guidance on chronic kidney disease
door: Landray, M, et al.
Gepubliceerd in: (2008)

TaleNeprilysin and Neprilysin inhibition in chronic kidney disease
door: Judge, PK, et al.
Gepubliceerd in: (2021)

The role of lipoprotein(a) in chronic kidney disease
door: Hopewell, J, et al.
Gepubliceerd in: (2018)

The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease
door: Refsum, H, et al.
Gepubliceerd in: (2006)

Kidney age, not kidney disease
door: Stevens, R, et al.
Gepubliceerd in: (2018)

Kidney age, not kidney disease
door: Stevens, R, et al.
Gepubliceerd in: (2019)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
door: Oulhaj, A, et al.
Gepubliceerd in: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
door: Oulhaj, A, et al.
Gepubliceerd in: (2010)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
door: Clarke, R, et al.
Gepubliceerd in: (2001)

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
door: Clarke, R, et al.
Gepubliceerd in: (1998)

Aspirin for primary prevention of vascular disease in people with diabetes.
door: Haynes, R, et al.
Gepubliceerd in: (2009)

Homocysteine: a risk factor for coronary artery disease?
door: Marinou, K, et al.
Gepubliceerd in: (2005)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
door: Nurk, E, et al.
Gepubliceerd in: (2005)